Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances

Urology. 2002 Aug;60(2):218-22. doi: 10.1016/s0090-4295(02)01739-9.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antigens, Neoplasm / analysis
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Carcinoma, Renal Cell / chemically induced
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Gastrointestinal Neoplasms / chemistry
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / pathology*
  • Humans
  • Imatinib Mesylate
  • Kidney Neoplasms / chemically induced
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / secondary
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / secondary
  • Proto-Oncogene Proteins c-kit / analysis
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*
  • Sarcoma / chemistry
  • Sarcoma / drug therapy*
  • Sarcoma / secondary*

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit